Acceptability of cognitive remediation for schizophrenia: a systematic review and meta-analysis of randomized controlled trials

被引:46
|
作者
Vita, Antonio [1 ,2 ]
Barlati, Stefano [1 ,2 ]
Ceraso, Anna [1 ]
Deste, Giacomo [2 ]
Nibbio, Gabriele [1 ]
Wykes, Til [3 ,4 ]
机构
[1] Univ Brescia, Dept Clin & Expt Sci, Brescia, Italy
[2] ASST Spedali Civili Brescia, Dept Mental Hlth & Addict Serv, Brescia, Italy
[3] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England
[4] Maudsley Hosp & Inst Psychiat, South London & Maudsley NHS Fdn Trust, Denmark Hill, London, England
关键词
Acceptability; cognitive remediation; drop-out; meta-analysis; schizophrenia; systematic review; PSYCHOSOCIAL TREATMENT; TRAINING-PROGRAM; LOW-SUPPORT; THERAPY; ADHERENCE; EFFICACY; OUTCOMES; IMPACT; BLIND; RATES;
D O I
10.1017/S0033291722000319
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background Acceptability is an important factor for predicting intervention use and potential treatment outcomes in psychosocial interventions. Cognitive remediation (CR) improves cognition and functioning in people with a diagnosis of schizophrenia, but its acceptability, and the impact of participants and treatment characteristics, remain to be investigated. Few studies provide a direct measure of acceptability, but treatment drop-out rates are often available and represent a valid surrogate. Method The systematic search conducted for the most comprehensive CR outcomes database for schizophrenia was updated in December 2020. Eligible studies were randomized clinical trials comparing CR with any other control condition in patients diagnosed with schizophrenia spectrum disorders and that also reported drop-out in treatment and control arms separately. Acceptability was measured as odd-ratios (OR) of drop-out. Results Of 2119 identified reports, 151 studies, reporting 169 comparisons between CR and control interventions with 10 477 participants were included in the analyses. The overall rate of drop-out was 16.58% for CR programs and 15.21% for control conditions. In the meta-analysis, no difference emerged between CR interventions and controls [OR 1.10, 95% confidence interval (CI) 0.96-1.25, p = 0.177]. Factors improving acceptability were: inpatient only recruitment, participants with fewer years of education and lower premorbid IQ, the presence of all CR core elements, and the presence of techniques to transfer cognitive gains into real-world functioning. Conclusions CR for people diagnosed with schizophrenia is effective and has a good acceptability profile, similar to that of other evidence-based psychosocial interventions.
引用
收藏
页码:3661 / 3671
页数:11
相关论文
共 50 条
  • [1] Efficacy of cognitive remediation in bipolar disorder: systematic review and meta-analysis of randomized controlled trials
    Samame, Cecilia
    Durante, Paula
    Cattaneo, Brenda
    Aprahamian, Ivan
    Strejilevich, Sergio
    PSYCHOLOGICAL MEDICINE, 2023, 53 (12) : 5361 - 5373
  • [2] Efficacy and tolerability of blonanserin in schizophrenia: A systematic review and meta-analysis of randomized controlled trials
    Tian, Jing
    Dong, Shimeng
    Nomura, Nobuyuki
    Siafis, Spyridon
    Lin, Xiao
    Wu, Hui
    Qin, Mengchang
    Yanagimoto, Hiroko
    Schneider-Thoma, Johannes
    Leucht, Stefan
    SCHIZOPHRENIA RESEARCH, 2024, 274 : 360 - 373
  • [3] Efficacy and tolerability of aripiprazole once monthly for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
    Oya, Kazuto
    Kishi, Taro
    Iwata, Nakao
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 2299 - 2307
  • [4] Adjunctive ondansetron for schizophrenia: A systematic review and meta-analysis of randomized controlled trials
    Zheng, Wei
    Cai, Dong-Bin
    Zhang, Qing-E.
    He, Jie
    Zhong, Li-Yun
    Sim, Kang
    Ungvari, Gabor S.
    Ning, Yu-Ping
    Xiang, Yu-Tao
    JOURNAL OF PSYCHIATRIC RESEARCH, 2019, 113 : 27 - 33
  • [5] Blonanserin for schizophrenia: Systematic review and meta-analysis of double-blind, randomized, controlled trials
    Kishi, Taro
    Matsuda, Yuki
    Nakamura, Hiroshi
    Iwata, Nakao
    JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (02) : 149 - 154
  • [6] Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials
    Oya, Kazuto
    Kishi, Taro
    Iwata, Nakao
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2014, 29 (05) : 483 - 491
  • [7] A systematic review and meta-analysis of cognitive remediation in early schizophrenia
    Revell, Emily R.
    Neill, Jo C.
    Harte, Michael
    Khan, Zarshed
    Drake, Richard J.
    SCHIZOPHRENIA RESEARCH, 2015, 168 (1-2) : 213 - 222
  • [8] A preliminary systematic review and meta-analysis of randomized-controlled trials of cognitive remediation therapy for anorexia nervosa
    Hagan, Kelsey E.
    Christensen, Kara A.
    Forbush, Kelsie T.
    EATING BEHAVIORS, 2020, 37
  • [9] Physical exercise for negative symptoms of schizophrenia: Systematic review of randomized controlled trials and meta-analysis
    Sabe, Michel
    Kaiser, Stefan
    Sentissi, Othman
    GENERAL HOSPITAL PSYCHIATRY, 2020, 62 : 13 - 20
  • [10] Efficacy and tolerability of topiramate-augmentation therapy for schizophrenia: a systematic review and meta-analysis of randomized controlled trials
    Okuyama, Yuji
    Oya, Kazuto
    Matsunaga, Shinji
    Kishi, Taro
    Iwata, Nakao
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 3221 - 3236